Senisca

About Senisca

Senisca is a biotech spin-out from the University of Exeter focused on developing senotherapeutics that target the aging process. The company concentrates on modulating RNA biology, particularly dysregulated RNA splicing, to reverse cellular senescence and treat age-related diseases. With a research-led approach, Senisca aims to reset splicing factor balance using oligonucleotide-based therapies, advancing interventions in aging and associated conditions. Headquartered in the UK, it collaborates with academic and industry partners to move regenerative aging research toward clinical impact.